PGP and heart failure: In the stepwise multiple linear regression model, eGFR, female sex, history of heart failure, body weight, age, and use of moderate or strong inhibitors of CYP3A4 or Pgp remained independent significant determinants of anti-Xa activity (p < 0.05).